Education
About Us
Working with TipRanks
Follow Us
Xenon Pharmaceuticals (XENE)
NASDAQ:XENE
Xenon (XENE) Ownership Overview
0.10% Insiders
30.46% Mutual Funds
54.12% Other Institutional Investors
6.24% ETFs
9.06% Public Companies and
Individual Investors
The ownership structure of Xenon (XENE) stock is a mix of institutional, retail, and individual investors. Approximately 90.83% of the company’s stock is owned by Institutional Investors, 0.10% is owned by Insiders, and 9.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 06, 2025 | xxxxxxxxxxxxx | $91 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $201874 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $5621000 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $167389927 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,169,114 | Institution | 5.40% | 192,112,773 | |
| 3,825,173 | Institution | 4.95% | 176,263,972 | |
| 3,543,197 | Institution | 4.59% | 163,270,518 | |
| 2,179,779 | Institution | 2.82% | 100,444,216 | |
| 2,035,707 | Institution | 2.63% | 93,805,379 | |
| 1,976,064 | Institution | 2.56% | 91,057,029 | |
| 1,450,758 | Institution | 1.88% | 66,850,929 | |
| 1,146,935 | Institution | 1.48% | 52,850,765 | |
| 1,077,880 | Institution | 1.39% | 49,668,710 | |
| 817,869 | Institution | 1.06% | 37,687,404 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,825,173 | Institution | 4.95% | 176,263,972 | |
| 2,179,779 | Institution | 2.82% | 100,444,216 | |
| 2,035,707 | Institution | 2.63% | 93,805,379 | |
| 1,976,064 | Institution | 2.56% | 91,057,029 | |
| 1,450,758 | Institution | 1.88% | 66,850,929 | |
| 1,146,935 | Institution | 1.48% | 52,850,765 | |
| 1,077,880 | Institution | 1.39% | 49,668,710 | |
| 817,869 | Institution | 1.06% | 37,687,404 | |
| 572,560 | Institution | 0.74% | 26,383,565 | |
| 568,203 | Institution | 0.74% | 26,182,794 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,978,483 | Institution | 2.56% | 87,251,100 | |
| 677,297 | Institution | 0.88% | 29,868,798 | |
| 529,309 | Institution | 0.68% | 23,342,527 | |
| 374,171 | Institution | 0.48% | 16,732,927 | |
| 140,405 | Institution | 0.18% | 6,191,861 | |
| 66,280 | Institution | 0.09% | 2,964,042 | |
| 62,889 | Institution | 0.08% | 2,773,405 | |
| 61,550 | Institution | 0.08% | 2,714,355 | |
| 56,793 | Institution | 0.07% | 2,455,161 | |
| 47,898 | Institution | 0.06% | 2,141,999 |
FAQ
Who Owns Xenon Pharmaceuticals (XENE)?
According to the latest TipRanks data, approximately 54.12% of the company's stock is held by institutional investors, 0.10% is held by insiders, and 9.06% is held by retail investors.
What percentage of Xenon Pharmaceuticals (XENE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.12% of Xenon Pharmaceuticals (XENE) stock is held by institutional investors.
What percentage of Xenon Pharmaceuticals (XENE) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.06% of Xenon Pharmaceuticals (XENE) stock is held by retail investors.
Who owns the most shares of Xenon Pharmaceuticals (XENE)?
Richard Driehaus owns the most shares of Xenon Pharmaceuticals (XENE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.